29 311

Cited 20 times in

Syndecan-1, a key regulator of cell viability in endometrial cancer.

Authors
Choi, DS; Kim, JH; Ryu, HS; Kim, HC; Han, JH; Lee, JS; Min, CK
Citation
International journal of cancer, 121(4):741-750, 2007
Journal Title
International journal of cancer
ISSN
0020-71361097-0215
Abstract
Syndecan-1 is one of the major proteoglycans on cell surfaces involved in major biological processes. Although loss of syndecan-1 correlates well with the gain of cancerous characteristics in a wide range of cancers, increased expression of syndecan-1 also coincides with adverse outcomes in some cancers, including breast, ovarian and pancreatic cancers. For this Janus-faced attitude of syndecan-1, we sought to examine expression patterns of syndecan-1 in endometrial carcinoma (EC) and gain insight into the roles of syndecan-1. Immunohistochemical examinations of 109 endometrial tissue samples from myoma, hyperplasia and EC uteri revealed that syndecan-1 expression was significantly upregulated in EC compared with hyperplasia (p < 0.001). To evaluate pathophysiological functions of syndecan-1, its expression level was altered, and subsequent outcomes were examined using human endometrial cancer cell lines such as HEC-1A, AN3CA and KLE cells. Overexpression of syndecan-1 increased the growth of HEC-1A cells regardless of anchorage dependence while silencing syndecan-1 by antisense RNAs caused apoptotic cell death. Consistent with decreased viability, the loss of syndecan-1 was also accompanied by a decrease in the activation of Erk and Akt and a concomitant decrease in the phosphorylation of PTEN and PDK1, which are known as negative and positive regulators of Akt activation, respectively. These down-regulatory effects were reversed upon overexpression of syndecan-1. Collectively together, the aforementioned findings lend support to the notion that upregulation of syndecan-1 may be a critical element for endometrial cancers in maintaining their viability and thus can serve as a cancer specific therapeutic and diagnostic marker.
MeSH terms
ApoptosisCell LineCell Line, TumorCell Survival*Endometrial Neoplasms/metabolism*Endometrial Neoplasms/pathologyEndometrium/metabolism*Extracellular Signal-Regulated MAP Kinases/metabolismFemaleHumansImmunohistochemistryPTEN Phosphohydrolase/metabolismPhosphorylationProto-Oncogene Proteins c-akt/metabolismRNA InterferenceSignal TransductionSyndecan-1/physiology*Up-Regulation
DOI
10.1002/ijc.22713
PMID
17455248
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Obstetrics & Gynecology
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
AJOU Authors
유, 희석한, 재호
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse